Redefining Care Delivery: How Infusion and Specialty Pharmacies Are Converging
July 24th 2025The decentralization of US health care, accelerated by virtual care adoption, shifting reimbursement models, and a growing demand for complex therapies, is elevating the role of specialty and infusion pharmacies as essential, tech-enabled partners in delivering coordinated, patient-centered care across outpatient and home-based settings.
Read More
Remnant Cholesterol, Independent of LDL-C, Serves as Predictor of MASLD
July 24th 2025High levels of remnant cholesterol were associated with increased risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD) independent of low-density lipoprotein cholesterol (LDL-C).
Read More
Delgocitinib Cream Becomes First, Only Approved Treatment for Moderate-to-Severe Chronic Hand Eczema
July 24th 2025The approval represents a major advancement for patients with moderate-to-severe chronic hand eczema, as delgocitinib becomes the first treatment available for this population in the US.
Read More
Pharmacists Can Tackle Thimerosal Misinformation Through Education, Empathy, and Transparency
July 23rd 2025Adam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.
Watch
Study: Biomarker May Aid in Identification and Prevention of Uranium Toxicity–Related CKD
Published: July 23rd 2025 | Updated: July 23rd 2025New research reveals uranium isotopes in urine as potential biomarkers for kidney damage, highlighting risks from contaminated drinking water in the US.
Read More
Harnessing AI to Streamline Clinical Trials, Optimize Pharmacy, and Personalize Cancer Treatment
July 23rd 2025Artificial intelligence (AI) is rapidly transforming oncology by enhancing clinical trial design, streamlining patient recruitment, improving precision medicine, and optimizing pharmacy operations, while raising important challenges around data ethics, bias, and integration into clinical workflows.
Read More
USP Expert Discusses Balancing Drug Cost, Quality, and Access in a Changing Trade Landscape
July 23rd 2025Carrie Harney, JD, of US Pharmacopeia (USP) discusses how proposed tariffs could impact generic drug supply chains, sterile injectable shortages, and pharmacy operations, underscoring the need for policy incentives and manufacturing diversification.
Read More